References
- 1. DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP, NATHAN DM, GENUTH S et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
- 2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-53.
- 3. ARONSON R, ORZECH N, YE C, BROWN RE, GOLDENBERG R, BROWN V. Specialist-Led Diabetes Registries and Prevalence of Poor Glycemic Control in Type 2 Diabetes: The Diabetes Registry Outcomes Project for A1C Reduction (DROP A1C). Diabetes Care 2016; 39:1711.
- 4. ALI MK, BULLARD KM, SAADDINE JB, COWIE CC, IMPERATORE G, GREGG EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013; 368:1613-24.
- 5. ROTER DL, HALL JA, MERISCA R, NORDSTROM B, CRETIN D, SVARSTAD B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998; 36:1138-61.
- 6. SCHECHTER CB, WALKER EA. Improving Adherence to Diabetes Self-Management Recommendations. Diabetes Spectrum 2002; 15:170.
- 7. CRAMER JA. A Systematic Review of Adherence with Medications for Diabetes. Diabetes Care 2004; 27:1218.
- 8. ROUMIE CL, ELASY TA, GREEVY R et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med 2006; 145:165-75.
- 9. OSTERBERG L, BLASCHKE T. Adherence to Medication. N Engl J Med 2005; 353:487-97.
- 10. MASNOON N, SHAKIB S, KALISCH-ELLETT L, CAUGHEY GE. What is polypharmacy? A systematic review of definitions. BMC Geriatrics 2017; 17:230.
- 11. GNJIDIC D, HILMER SN, BLYTH FM et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012; 65:989-95.
- 12. PERON EP, OGBONNA KC, DONOHOE KL. Diabetic Medications and Polypharmacy. Clin Geriatr Med 2015; 31:17-vii.
- 13. ROCHON PA, GURWITZ JH. Optimising drug treatment for elderly people: the prescribing cascade. British Medical Journal 1997; 315:1096-9.
- 14. American Diabetes Association. Standards of medical care in diabetes – 2014. Diabetes Care 2014; 37 Suppl 1: S14-80.
- 15. WIMMER BC, CROSS AJ, JOKANOVIC N et al. Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review. J Am Geriatr Soc 2017; 65:747-53.
- 16. MORISKY DE, GREEN LW, LEVINE DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24:67-74.
- 17. R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing 2017.
- 18. ODEGARD PS, CAPOCCIA K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007; 33:1014, 29; discussion 1030-1.
- 19. BURKHART PV, SABATE E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003; 35:207.
- 20. TIV M, VIEL JF, MAUNY F et al. Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study. PLoS One 2012; 7:e32412. doi:10.1371/journal.pone.0032412.10.1371/journal.pone.0032412
- 21. Slone Epidemiology Center Patterns of medication use in the United States. 2006; 2017.
- 22. COOPER JA, CADOGAN CA, PATTERSON SM, KERSE N, BRADLEY MC, RYAN C, HUGHES CM. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open 2015; 5:e009235, 2015-009235.